Michael S. Ominsky, Ph.D.

Affiliations: 
2003 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Molecular and Cellular Biomechanics, Organ and Whole Body Biomechanics, Tissue Engineering and Regenerative Medicine
Google:
"Michael Ominsky"
Mean distance: 9.03
 

Parents

Sign in to add mentor
Steven A. Goldstein grad student 2003 University of Michigan
 (Effects of hydrostatic pressure, biaxial strain, and fluid shear on osteoblastic cells: Mechanotransduction via NF-kappaB, MAP kinase, and AP-1 pathways.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Florio M, Kostenuik PJ, Stolina M, et al. (2023) Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured BoneAn Experimental Study in Nonhuman Primates. The Journal of Bone and Joint Surgery. American Volume
Cardinal M, Chretien A, Roels T, et al. (2021) Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse. Frontiers in Genetics. 12: 705505
Arlt H, Besschetnova T, Ominsky MS, et al. (2021) Effects of systemically administered abaloparatide, an osteoanabolic PTHrP analog, as an adjuvant therapy for spinal fusion in rats. Jor Spine. 4: e1132
Dempster DW, Zhou H, Rao SD, et al. (2021) Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women with Osteoporosis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research
Arlt H, Mullarkey T, Hu D, et al. (2020) Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice. Bone Reports. 13: 100291
Cardinal M, Dessain A, Roels T, et al. (2020) Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice. Calcified Tissue International
Besschetnova T, Brooks DJ, Hu D, et al. (2019) Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis. Bone
Cardinal M, Tys J, Roels T, et al. (2019) Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta. Bone. 124: 137-147
Lanske B, Chandler H, Pierce A, et al. (2019) Abaloparatide, a PTH Receptor Agonist with Homology to PTHrP, Enhances Callus Bridging and Biomechanical Properties in Rats with Femoral Fracture. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
Chandler H, Lanske B, Varela A, et al. (2018) Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption. Bone
See more...